Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy

Yinlong Zhang, Guangna Liu, Jingyan Wei, Guangjun Nie

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations


Platelets have long been known to play critical roles in hemostasis by clumping and clotting blood vessel injuries. Recent experimental evidence strongly indicates that platelets can also interact with tumor cells by direct binding or secreting cytokines. For example, platelets have been shown to protect circulating cancer cells in blood circulation and to promote tumor metastasis. In-depth understanding of the role of platelets in cancer progression and metastasis provides promising approaches for platelet biomimetic drug delivery systems and functional platelet-targeting strategies for effective cancer treatment. This review highlights recent progresses in platelet membrane-based drug delivery and unique strategies that target tumor-associated platelets for cancer therapy. The paper also discusses future development opportunities and challenges encountered for clinical translation.

Original languageEnglish (US)
Pages (from-to)667-677
Number of pages11
JournalFrontiers of Medicine
Issue number6
StatePublished - Dec 1 2018


  • EPR effect
  • cancer therapy
  • platelet-mimicking delivery systems
  • tumor-associated platelets

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy'. Together they form a unique fingerprint.

Cite this